THE ROLE OF GLUTAMATE IN THE LOCUS-COERULEUS DURING OPIOID WITHDRAWALAND EFFECTS OF H-7, A PROTEIN-KINASE INHIBITOR, ON THE ACTION OF GLUTAMATE IN RATS
S. Tokuyama et al., THE ROLE OF GLUTAMATE IN THE LOCUS-COERULEUS DURING OPIOID WITHDRAWALAND EFFECTS OF H-7, A PROTEIN-KINASE INHIBITOR, ON THE ACTION OF GLUTAMATE IN RATS, Journal of biomedical science, 5(1), 1998, pp. 45-53
To investigate the role of glutamate in the locus coeruleus (LC) durin
g opioid withdrawal, rats were continuously infused with morphine (a m
u-opioid receptor agonist, 26 nmol/mu l/h) or butorphanol (a mu/delta/
kappa-mixed opioid receptor agonist, 26 nmol/mu l/h) intracerebroventr
icularly (i.c.v.) via osmotic minipumps for 3 days. A direct LC inject
ion of glutamate (1 or 10 nmol/5 mu l) or naloxone (an opioid receptor
antagonist, 24 nmol/5 mu l) induced withdrawal signs in morphine- or
butorphanol-dependent animals. However, these agents failed to precipi
tate any withdrawal signs in saline-treated control animals. On the ot
her hand, the expression of withdrawal signs precipitated by the admin
istration of glutamate or naloxone in opioid-dependent animals was com
pletely blocked by concomitant infusion with 1 or 10 nmol/mu l/h of an
inhibitor of adenosine 3',5'-cyclic monophosphate (cAMP)-dependent pr
otein kinase and protein kinase C, H-7 [1-(5-isoquinolinesulfonyl)-2-m
ethylpiperazine]. In animals that had been infused with opioids in the
same manner, i.c.v. injection of naloxone (48 nmol/5 mu l) precipitat
ed withdrawal signs and increased extracellular fluid levels of glutam
ate in the LC of morphine- or butorphanol-dependent rats measured by i
n vivo microdialysis method. However, concomitant infusion with H-7 in
hibited the increases of glutamate levels in the LC. These results str
ongly suggest that an expeditious release of glutamate in the LC regio
n plays an important role in the expression of physical dependence on
opioids. Furthermore, the action on glutamate release might be increas
ed by the enhancement of cAMP-dependent protein kinase and/or protein
kinase C activity.